QPS Austria GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:QPS Austria GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014009
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization that performs preclinical and clinical research. The company offers in vivo services which involves generating, characterizing and maintaining transgenic disease models and use them for drug testing projects. Its in vitro services provides various standardized cell culture systems that includes transgenic and non-transgenic cell lines, glial cells, central nervous system neurons of developmental stages and organotypic brain slices. QPS’s offers drug development services for neurodegenerative diseases that include Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, schizophrenia, amyotrophic lateral sclerosis, and others. The company offers histological services ranging from collection of tissue samples to delivering study reports. QPS is headquartered in Grambach, Austria.

QPS Austria GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
QPS Austria GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
QPS Austria GmbH, Medical Devices Deals, 2011 to YTD 2017 9
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
TCG Lifesciences Enters Into Agreement With JSW Lifesciences 13
Porsolt Enters Into Co-Marketing Agreement With JSW Life Sciences 14
Licensing Agreements 15
QPS Austria Enters into Licensing Agreement with Probiodrug 15
Acquisition 16
QPS Acquires Majority Stake In JSW Lifesciences 16
QPS Austria GmbH – Key Competitors 17
QPS Austria GmbH – Key Employees 18
QPS Austria GmbH – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
QPS Austria GmbH, Pharmaceuticals & Healthcare, Key Facts 2
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
QPS Austria GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
QPS Austria GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
QPS Austria GmbH, Medical Devices Deals, 2011 to YTD 2017 9
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
TCG Lifesciences Enters Into Agreement With JSW Lifesciences 13
Porsolt Enters Into Co-Marketing Agreement With JSW Life Sciences 14
QPS Austria Enters into Licensing Agreement with Probiodrug 15
QPS Acquires Majority Stake In JSW Lifesciences 16
QPS Austria GmbH, Key Competitors 17
QPS Austria GmbH, Key Employees 18

★海外企業調査レポート[QPS Austria GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Nippon Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Reliance Nippon Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Nippon Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Phoenix Pharmahandel GmbH & Co KG:企業の戦略的SWOT分析
    Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Southwest Gas Holdings Inc:企業の戦略・SWOT・財務情報
    Southwest Gas Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Southwest Gas Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Augmenix Inc-医療機器分野:企業M&A・提携分析
    Summary Augmenix Inc (Augmenix) is a medical device company that develops space-filling hydrogels for radiation oncology and cancer surgery indications. The company offers products such as hydrogel products, space OAR systems, absorbable tissue marker, and trace-IT hydrogel products. Its TraceIT hyd …
  • Leigh Creek Energy Ltd (LCK):企業の財務・戦略的SWOT分析
    Leigh Creek Energy Ltd (LCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Pfizer Inc.:企業の戦略・SWOT・財務情報
    Pfizer Inc. - Strategy, SWOT and Corporate Finance Report Summary Pfizer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Andersen Construction Co:企業の戦略的SWOT分析
    Andersen Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ABO Wind AG:企業の戦略的SWOT分析
    ABO Wind AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SEACOR Holdings Inc.:企業の戦略・SWOT・財務分析
    SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Danaher Corporation (DHR)-医療機器分野:企業M&A・提携分析
    Summary Danaher Corporation (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. The company offers a wide range of testing instruments, communications solutions, water quality systems, medical diagn …
  • Changmao Biochemical Engineering Co., Ltd:戦略・SWOT・企業財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Canon USA Inc-医療機器分野:企業M&A・提携分析
    Summary Canon U.S.A. Inc (Canon), a subsidiary of Canon Inc, is a technology company that designs, develops and commercializes imaging equipment and information systems, and digital imaging solutions. The company offers products which include cameras and camcorders, lenses, flashes and binoculars, o …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業の財務・戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (Amara Raja) is a manufacturer of lead-acid storage batteries. The company operates through two divisions such as automotive battery and industrial battery division. Its automotive battery division offers two-wheeler batteries, four-wheeler batteries and tubular batt …
  • GeoVax Labs Inc (GOVX):製薬・医療:M&Aディール及び事業提携情報
    Summary GeoVax Labs Inc (GeoVax) develops human vaccines for diseases caused by human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus on HIV, Zika virus …
  • Jones Lang LaSalle Inc (JLL):企業の財務・戦略的SWOT分析
    Jones Lang LaSalle Inc (JLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sunquest Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sunquest Information Systems Inc (Sunquest), a subsidiary of Roper Technologies, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory informatics such as labora …
  • Shimadzu Corp (7701):企業の財務・戦略的SWOT分析
    Shimadzu Corp (7701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆